Literature DB >> 28695376

Heterozygous carriers of succinyl-CoA:3-oxoacid CoA transferase deficiency can develop severe ketoacidosis.

Hideo Sasai1, Yuka Aoyama1,2, Hiroki Otsuka1, Elsayed Abdelkreem1,3, Yasuhiro Naiki4, Mitsuru Kubota5, Yuji Sekine6, Masatsune Itoh7, Mina Nakama8, Hidenori Ohnishi1, Ryoji Fujiki9, Osamu Ohara9, Toshiyuki Fukao10,11.   

Abstract

Succinyl-CoA:3-oxoacid CoA transferase (SCOT, gene symbol OXCT1) deficiency is an autosomal recessive disorder in ketone body utilization that results in severe recurrent ketoacidotic episodes in infancy, including neonatal periods. More than 30 patients with this disorder have been reported and to our knowledge, their heterozygous parents and siblings have had no apparent ketoacidotic episodes. Over 5 years (2008-2012), we investigated several patients that presented with severe ketoacidosis and identified a heterozygous OXCT1 mutation in four of these cases (Case1 p.R281C, Case2 p.T435N, Case3 p.W213*, Case4 c.493delG). To confirm their heterozygous state, we performed a multiplex ligation-dependent probe amplification analysis on the OXCT1 gene which excluded the presence of large deletions or insertions in another allele. A sequencing analysis of subcloned full-length SCOT cDNA showed that wild-type cDNA clones were present at reasonable rates to mutant cDNA clones. Over the following 2 years (2013-2014), we analyzed OXCT1 mutations in six more patients presenting with severe ketoacidosis (blood pH ≦7.25 and total ketone body ≧10 mmol/L) with non-specific urinary organic acid profiles. Of these, a heterozygous OXCT1 mutation was found in two cases (Case5 p.G391D, Case6 p.R281C). Moreover, transient expression analysis revealed R281C and T435N mutants to be temperature-sensitive. This characteristic may be important because most patients developed ketoacidosis during infections. Our data indicate that heterozygous carriers of OXCT1 mutations can develop severe ketoacidotic episodes in conjunction with ketogenic stresses.

Entities:  

Keywords:  Heterozygous carriers; Ketoacidosis; OXCT1; SCOT deficiency

Mesh:

Substances:

Year:  2017        PMID: 28695376     DOI: 10.1007/s10545-017-0065-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  37 in total

1.  A new case of succinyl-CoA:acetoacetate transferase deficiency: favourable course despite very low residual activity.

Authors:  I Barić; V Sarnavka; K Fumić; M Maradin; D Begović; J P Ruiter; R J Wanders
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

Review 2.  Nonsense-mediated mRNA decay in mammals.

Authors:  Lynne E Maquat
Journal:  J Cell Sci       Date:  2005-05-01       Impact factor: 5.285

3.  Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency.

Authors:  G T Berry; T Fukao; G A Mitchell; A Mazur; M Ciafre; J Gibson; N Kondo; M J Palmieri
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  A neonatal-onset succinyl-CoA:3-ketoacid CoA transferase (SCOT)-deficient patient with T435N and c.658-666dupAACGTGATT p.N220_I222dup mutations in the OXCT1 gene.

Authors:  Toshiyuki Fukao; Tomohiro Ishii; Naoko Amano; Petri Kursula; Masaki Takayanagi; Keiko Murase; Naomi Sakaguchi; Naomi Kondo; Tomonobu Hasegawa
Journal:  J Inherit Metab Dis       Date:  2010-07-21       Impact factor: 4.982

6.  A 6-bp deletion at the splice donor site of the first intron resulted in aberrant splicing using a cryptic splice site within exon 1 in a patient with succinyl-CoA: 3-Ketoacid CoA transferase (SCOT) deficiency.

Authors:  Toshiyuki Fukao; Satomi Sakurai; Marie-Odile Rolland; Marie-Therese Zabot; Andreas Schulze; Keitaro Yamada; Naomi Kondo
Journal:  Mol Genet Metab       Date:  2006-06-12       Impact factor: 4.797

7.  Succinyl CoA: 3-oxoacid CoA transferase (SCOT): human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient.

Authors:  S Kassovska-Bratinova; T Fukao; X Q Song; A M Duncan; H S Chen; M F Robert; C Pérez-Cerdá; M Ugarte; C Chartrand; S Vobecky; N Kondo; G A Mitchell
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

8.  Patients homozygous for the T435N mutation of succinyl-CoA:3-ketoacid CoA Transferase (SCOT) do not show permanent ketosis.

Authors:  Toshiyuki Fukao; Haruo Shintaku; Ryou Kusubae; Gai X Zhang; Kozue Nakamura; Masashi Kondo; Naomi Kondo
Journal:  Pediatr Res       Date:  2004-10-20       Impact factor: 3.756

9.  Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy.

Authors:  J T Tildon; M Cornblath
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

10.  Prenatal diagnosis of succinyl-coenzyme A:3-ketoacid coenzyme A transferase deficiency.

Authors:  T Fukao; X Q Song; H Watanabe; K Hirayama; H Sakazaki; H Shintaku; M Imanaka; T Orii; N Kondo
Journal:  Prenat Diagn       Date:  1996-05       Impact factor: 3.050

View more
  2 in total

1.  A case of severe acidosis in a 12-month-old: Succinyl-CoA:3-ketoacid-CoA transferase deficiency with OXCT1 gene mutations.

Authors:  Navjot Dhammi; Jenna Essakow; Renata Gallagher; Cynthia Gaw
Journal:  SAGE Open Med Case Rep       Date:  2022-07-12

Review 2.  Cardiac Complications of Propionic and Other Inherited Organic Acidemias.

Authors:  Kyung Chan Park; Steve Krywawych; Eva Richard; Lourdes R Desviat; Pawel Swietach
Journal:  Front Cardiovasc Med       Date:  2020-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.